SEMPRA (SRE)
SEMPRA (SRE)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 1,150 | 484 | 150 | 519 |
| Regulatory disallowances | NaN | 651 | NaN | NaN |
| Depreciation and amortization | 621 | 608 | 662 | 653 |
| Deferred income taxes and investment tax credits | 124 | -25 | 430 | 176 |
| Equity earnings | 367 | 414 | 472 | 393 |
| Share-based compensation expense | 25 | 39 | 14 | 13 |
| Fixed-price contracts and other derivatives | 9 | 41 | -51 | 52 |
| Bad debt expense | 18 | -44 | 72 | 31 |
| Other | -8 | 19 | -39 | 33 |
| Accounts receivable | NaN | 66 | NaN | NaN |
| Due to/from unconsolidated affiliates, net | NaN | -17 | NaN | NaN |
| Income taxes receivable/payable, net | NaN | -187 | NaN | NaN |
| Inventories | NaN | 64 | NaN | NaN |
| Other current assets | NaN | 296 | NaN | NaN |
| Accounts payable | NaN | -7 | NaN | NaN |
| Regulatory balancing accounts, net | NaN | 829 | NaN | NaN |
| Other current liabilities | NaN | 177 | NaN | NaN |
| Net change in working capital components | -557 | NaN | 218 | 250 |
| Distributions from investments | 389 | 292 | 312 | 225 |
| Changes in other noncurrent assets and liabilities, net | 239 | -168 | -99 | -108 |
| Net cash provided by operating activities | 1,809 | 1,189 | 1,110 | 784 |
| Expenditures for property, plant and equipment | 2,461 | 3,411 | 2,561 | 2,304 |
| Expenditures for investments | 876 | 523 | 520 | 486 |
| Return on investments | NaN | 0 | NaN | NaN |
| Purchases of nuclear decommissioning and other trust assets | 368 | 285 | 215 | 239 |
| Proceeds from sales of nuclear decommissioning and other trust assets | 395 | 267 | 251 | 251 |
| Other | 1 | -20 | -3 | 0 |
| Net cash used in investing activities | -3,311 | -3,932 | -3,042 | -2,778 |
| Common dividends paid | 409 | 408 | 408 | 407 |
| Preferred dividends paid | NaN | 18 | 0 | 22 |
| Redemption of preferred stock | NaN | 900 | NaN | NaN |
| Issuances of common stock, net | 9 | 6 | 7 | 9 |
| Repurchases of common stock | 20 | 0 | 0 | 1 |
| Issuances of debt (maturities greater than 90 days) | 3,345 | 2,390 | 3,434 | 2,517 |
| Payments on debt (maturities greater than 90 days) and finance leases | 673 | 1,078 | 731 | 2,417 |
| Decrease in short-term debt, net | -458 | 1,432 | -852 | 752 |
| Advances from unconsolidated affiliates | 63 | 54 | 52 | 0 |
| Contributions from contingently redeemable noncontrolling interest, net of transaction costs | NaN | 2,082 | 3,212 | NaN |
| Proceeds from investor equity subscription | NaN | 0 | 106 | NaN |
| Proceeds from sales of noncontrolling interests, net | NaN | 0 | NaN | NaN |
| Contributions from noncontrolling interests | 41 | 190 | 54 | 49 |
| Distributions to noncontrolling interests | 65 | 478 | 40 | 53 |
| Termination of interest rate and settlement of cross-currency swaps | NaN | 0 | NaN | NaN |
| Termination of interest rate swaps, net of transaction costs | 96 | NaN | NaN | NaN |
| Other | -17 | -3 | -64 | -12 |
| Net cash provided by financing activities | 1,912 | 3,269 | 4,770 | 415 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -7 | NaN | 3 | 1 |
| Less increase in cash held for sale | NaN | NaN | NaN | 1 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | NaN | 5 | NaN | NaN |
| Increase in cash, cash equivalents and restricted cash | 407 | 527 | 2,842 | -1,579 |
| Cash, cash equivalents and restricted cash, january 1 | 3,552 | -1,436 | 0 | 1,589 |
| Cash, cash equivalents and restricted cash, june 30 | NaN | NaN | NaN | -1,579 |
| Cash, cash equivalents and restricted cash, march 31 | 3,959 | 527 | 1,436 | NaN |